Does pathologic complete response impact your selection criteria for tumor bed boost of breast cancer patients status post neoadjuvant chemotherapy and breast conserving surgery?
Answer from: Radiation Oncologist at Academic Institution
I have not used response, including pathologic complete response, as a reason to change my criteria for tumor bed boost following neoadjuvant chemotherapy. I typically will boost patients that meet at least one of the following criteria: age < 50, ER-, cT3, grade 3, LVSI.
Comments
Radiation Oncologist at PEACHTREE RADIATION ONCOLOGY SERVICES, P.C. Do you not consider DCIS component as a criteria f...
Radiation Oncologist at Joseph Kam Chiu, MD What is your criteria for scar boost after mastect...
Radiation Oncologist at Cleveland Clinic I do not typically consider DCIS component or EIC ...
Radiation Oncologist at Tennessee Oncology Thank you, Dr. Shah. While it appears pCR does not...
Radiation Oncologist at Cleveland Clinic It's a good question. We are currently evaluating ...
Radiation Oncologist at Varian Medical Systems/Allegheny health network There are studies showing her2neu positive breast ...
Radiation Oncologist at Weatherby Health Care Thank you for your thoughtful responses.
Dr. Pelt...
Do you not consider DCIS component as a criteria f...
What is your criteria for scar boost after mastect...
I do not typically consider DCIS component or EIC ...
Thank you, Dr. Shah. While it appears pCR does not...
It's a good question. We are currently evaluating ...
There are studies showing her2neu positive breast ...
Thank you for your thoughtful responses. Dr. Pelt...